EP Insights » Atrial fibrillation

Guest Blogger: RAAFT 2 Trial Summary

Heart Rhythm Society — Sat, 19 May 2012 10:00:46 +0000

Editor’s Note: Guest blogger Aman Chugh, MD provides a summary of the RAAFT 2 trial results, which were presented at the Heart Rhythm Society’s 33rd Annual Scientific Sessions in Boston. Catheter ablation of symptomatic paroxysmal atrial fibrillation (AF) is a class I indication in a patient who has not responded to or has not tolerated medical [...]

Guest Blogger: Live Case Sessions Review

Heart Rhythm Society — Fri, 11 May 2012 16:07:44 +0000

Editor’s Note: Guest blogger Kenneth Ellenbogen, MD, FHRS shares his thoughts on the live case session presented at the Heart Rhythm Society’s 33rd Annual Scientific Sessions. Yesterday I attended the Live Cases Session at Heart Rhythm 2012 in Boston. The group at Brigham and Women’s Hospital, led by Dr. Gregory Michaud, performed catheter ablation of a [...]

EP News, Basic and Translational

Peng-Sheng Chen, MD, FHRS — Thu, 05 Apr 2012 10:00:33 +0000

Circadian Variation of Ion Channel Expression The susceptibility to ventricular arrhythmia or sudden death is determined by the duration (e.g. short or long QT syndromes and heart failure) or pattern (e.g. Brugada syndrome) of ventricular repolarization. It is also known that there is circadian variation of the susceptibility to ventricular arrhythmias. However, the molecular mechanism [...]

HRS Picks: Many Americans in the Dark about Heart Rhythm Disorders

Heart Rhythm Society — Tue, 06 Mar 2012 18:41:59 +0000

In the article below, published on the blog, Be Healthy, Well & Inspired, the Heart Rhythm Society’s omnibus survey results about Americans understanding of heart rhythm disorers are shared with readers. The Society also issued a press release about the results during Heart Health month. Article Snippet: According to a new survey issued by the Heart Rhythm Society, the [...]

Support HRS’ Advocacy Efforts- Participate in the Virtual Fly-in

Kathleen Blake, MD, MPH, FHRS — Thu, 23 Feb 2012 11:00:26 +0000

The Heart Rhythm Society, in collaboration with other stakeholders, is educating Members of Congress, their staff and the public about heart rhythm disorders. During the American Heart Month, HRS is organizing a virtual fly-in on February 23. We ask HRS members and non-members to email their House Representatives and urge them to co-sponsor the AF [...]

Guest Blogger: Boston AF Symposium Highlights

Heart Rhythm Society — Fri, 27 Jan 2012 10:00:39 +0000

Editor’s Note: Guest blogger Hugh Calkins, MD, FHRS, CCDS is the Heart Rhythm Scientific Sessions Program Committee Chair (2012). He provides a brief overview of the Boston AF Symposium, which took place January 12 – 14, 2012. This year’s Boston AF Symposium was very well attended, with more than 1,200 participants. I would like to [...]

EP News: Basic and Translational

Peng-Sheng Chen, MD, FHRS — Tue, 10 Jan 2012 13:56:37 +0000

Genetic Testing as a Class I Indication for Patient Care Gersh et al (Circulation 2011;13:124, PMID 22068435) updated the ACCF/AHA Guideline for the Diagnosis and treatment of Hypertrophic Cardiomyopathy (HCM). In this updated recommendation for HCM, genetic testing is listed as a Class I recommendation to evaluate patients with HCM. All patients who undergo genetic [...]

EP News: Basic and Translational

Peng-Sheng Chen, MD, FHRS — Thu, 06 Oct 2011 13:39:14 +0000

Defibrillation with High-Frequency Electric Field Tandri et al (Sci Transl Med 2011;3:102ra96) studied the effects of electrical stimulation on conduction block in cardiac tissues. Electrical stimulation has been applied to nervous tissue to cause reversible conduction block, but has not been explored sufficiently in cardiac tissue. The authors show that reversible propagation block can be [...]

Guest Blogger: Atrial Fibrillation and Stroke – Education for the Public

Heart Rhythm Society — Wed, 28 Sep 2011 10:00:47 +0000

Editor’s Note: Guest blogger Aman Chugh, MD, is an assistant professor in the Division of Cardiology, University of Michigan. In his post, he aims to educate the public about atrial fibrillation and its relation to stroke. Although atrial fibrillation (AF) is usually not a life threatening arrhythmia, it may still result in significant morbidity. It [...]

HRS Update: FDA Issues Alert on the Heart Drug Multaq (dronedarone)

Heart Rhythm Society — Fri, 22 Jul 2011 15:54:44 +0000

The U.S. Food and Drug Administration (FDA) is reviewing data from the Permanent Atrial Fibrillation Outcome Study Using Dronedarone on Top of Standard Therapy (PALLAS) study that was evaluating the effects of the antiarrhythmic drug Multaq (dronedarone) in patients with permanent atrial fibrillation. The study was stopped early after the data monitoring committee found a two-fold increase in death, [...]